Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer

Combination chemotherapy is an established approach used to manage toxicities while eliciting an enhanced therapeutic response. Delivery of drug combinations at specific molar ratios has been considered a means to achieve synergistic effects resulting in improvements in efficacy while minimizing dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lucy, Evans, James C., Ahmed, Lubabah, Allen, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958112/
https://www.ncbi.nlm.nih.gov/pubmed/36828860
http://dx.doi.org/10.1038/s41598-023-28424-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958112/
https://www.ncbi.nlm.nih.gov/pubmed/36828860
http://dx.doi.org/10.1038/s41598-023-28424-3

Ejemplares similares